The studies presented by Kan et al. [19] revealed the association of Nucb2-induced colon cancer metastasis with the liver kinase B1 (LKB1), 5’AMP-activated protein kinase (AMPK), and mTOR (mammalian target of rapamycin) pathways [19]. The gene discussed is MTOR; the disease is colonic neoplasm.